Evidence Building

August 2023: Documenting patents for O-1

Expert analysis of recent developments and their impact on O-1 petitioners. Key takeaways inside.

Aug 21, 2023 · 8 min read

Why patent evidence matters in O-1A extraordinary ability petitions

Patents are one of the most concrete forms of evidence of original contribution available in an O-1A petition. A patent that has been granted by the United States Patent and Trademark Office (USPTO) or a foreign patent office represents a formal, government-issued certification that the claimed invention is novel, non-obvious, and useful—criteria that, while different from the O-1A extraordinary ability standard, are independently probative of the inventor's original contributions to their technical field. When presented with expert letters that explain the patent's technical significance and contextual importance within the field, patent evidence can satisfy the original contribution criterion at 8 C.F.R. § 214.2(o)(3)(ii)(C) and may also contribute to the recognition and high salary criteria.

USCIS has long accepted patent evidence as relevant to the original contributions criterion, and the USCIS Policy Manual specifically acknowledges that patents may be probative of extraordinary ability. However, holding a patent alone is not sufficient to establish that the contribution is of major significance to the field—the standard requires not just that the contribution is original but that it has had an impact on how others in the field work. A patent that describes an invention that has been widely licensed, commercially adopted, or cited in subsequent patents and scholarly literature presents a much stronger original contribution case than a patent that has never been licensed or commercialized and has not generated subsequent citations or adoptions.

The O-1A petition that relies on patent evidence faces a translation challenge: adjudicators are not patent attorneys or technical specialists, and the significance of a patent's claims—whether the invention represents a major technical advance or a minor incremental improvement—is not apparent from the patent document itself without expert context. This translation challenge is why expert letters are indispensable in patent-reliant O-1A petitions: the expert who can explain, in language accessible to a non-specialist, why the beneficiary's patent covers an invention that represents a meaningful advance in the field, and why that advance has been recognized by others in the field through licensing, citation, or adoption, provides the interpretive layer that turns the patent document into persuasive extraordinary ability evidence.

What USCIS looks for in patent documentation

When USCIS adjudicators review patent evidence in an O-1A petition, they assess several dimensions: the nature of the patented invention and its relevance to the beneficiary's field of extraordinary ability; the status of the patent (whether it is issued or pending, and whether the beneficiary is a named inventor); the commercial or technical impact of the invention as evidenced by licensing records, adoption metrics, or citation data; and any independent recognition of the patent's significance from expert letters, press coverage, or other sources. The adjudicator is not evaluating the technical merit of the patent claims—that was done by the patent examiner—but rather whether the patent's existence and impact satisfy the original contributions criterion as defined by the O-1A regulations.

The most straightforward patents for O-1A purposes are those where the commercial significance is documentable: a patent that has been licensed to multiple companies, assigned to a publicly recognizable technology enterprise, included in a declared standards-essential patent portfolio, or cited extensively in subsequent patents by other inventors has documentation of impact that goes beyond the patent document itself. USPTO patent citation data, available through the USPTO's Patent Center and through services such as Google Patents, shows how many subsequent patents have cited a given patent and who the citing inventors are. A patent that has been cited by a large number of subsequent inventors, particularly inventors at well-known companies or academic institutions, demonstrates that the invention was significant enough to be used as prior art or foundational reference by subsequent innovators.

USCIS has asked for evidence of the significance of patents beyond the patent grant itself in several contexts, and practitioners should anticipate this inquiry by presenting robust supporting documentation proactively rather than waiting for an RFE. The supporting documentation package for a patent should include: a copy of the issued patent or published application; a search of USPTO or Google Patents citation data showing the patent's citation record; any licensing agreements, press coverage, or industry references that document the patent's commercial or technical significance; and expert letters from practitioners in the relevant technical field who can assess the patent's significance in non-technical terms.

Granted patents versus pending applications: evidentiary weight

A granted patent—one that has completed examination at the USPTO or a foreign patent office and has been issued—carries substantially more evidentiary weight than a pending patent application. The grant is a governmental determination that the claimed invention is novel and non-obvious; it represents an independent evaluation of the invention's originality that is not present in a pending application where examination has not yet been completed. USCIS treats granted patents as stronger evidence of original contribution because the grant provides an external validation of the invention's novelty that is missing from a pending application.

Pending patent applications can still be submitted as evidence in an O-1A petition, but they should be presented as supporting context rather than as primary criterion evidence. A petitioner who has filed multiple patent applications in a field that is advancing rapidly—where the filing-to-grant timeline is longer than the petition planning horizon—may have a substantial portfolio of pending applications that, together with granted patents and other evidence, collectively demonstrate an active record of original contribution to the field. The pending applications in this context illustrate the breadth and current nature of the beneficiary's inventive work, while the granted patents provide the formal validation that carries primary evidentiary weight.

International patents—those granted by foreign patent offices such as the European Patent Office (EPO), the Japan Patent Office (JPO), the Korean Intellectual Property Office (KIPO), the China National Intellectual Property Administration (CNIPA), or through the Patent Cooperation Treaty (PCT) process—are acceptable evidence in O-1A petitions and are treated comparably to US patents when they have been granted by recognized foreign patent authorities. A PCT application that has entered the national phase in multiple jurisdictions and has been granted in several countries demonstrates that the invention has been independently evaluated as novel and non-obvious across multiple patent examination systems. This multi-jurisdictional grant provides additional validation of the invention's significance and can be cited as evidence of international recognition of the beneficiary's original contribution.

Assembling patent citation evidence

Patent citation analysis is a standard tool in patent valuation and technology assessment, and the methodology translates directly to the O-1A evidence context. The most accessible tool for patent citation research is Google Patents, which provides a citation count and a list of citing patents for any patent in its database. USPTO's Patent Center also provides citation data for US patents. For a more comprehensive analysis—particularly for patents in areas where international citations are important—Derwent Innovation (a Clarivate product), PatSnap, and LexisNexis PatentAdvisor provide commercial patent analytics that can generate citation reports with institutional attribution.

The relevant metrics for O-1A patent citation evidence are: the total number of forward citations (how many subsequent patents have cited the patent being documented), the institutional diversity of the citing patents (whether citations come from a range of independent inventors and organizations rather than from the same company or research group), and the presence of citations from recognized organizations whose patents in the relevant field are themselves widely cited. A patent cited by inventors at companies such as Google, Apple, Microsoft, Intel, NVIDIA, or major research universities in the relevant technical area has received recognition from organizations whose technical standing is itself well-established, and those citations are more probative than an equivalent number of citations from smaller, less recognized sources.

The citation analysis should be presented in the petition in a format that is accessible to a non-technical adjudicator. A one-page summary that states the patent number, the title of the invention in plain language, the grant date, the total citation count, the number of unique citing entities, and two or three notable examples of citing organizations—with a brief explanation of why each is a recognized authority in the relevant technical field—gives the adjudicator a clear picture of the patent's significance without requiring the adjudicator to conduct independent research. The expert letter then contextualizes this data within the field's citation norms, explaining what the citation count means relative to the median citation count for comparable patents in the same technical area.

Combining patent evidence with original contribution expert letters

Patent evidence and expert letters work together in an O-1A petition: the patent documentation establishes that the invention exists and provides the citation data, while the expert letters explain what the invention does, why it matters, and how it compares to other inventions in the field. Expert letters for patent-based original contribution claims should be written by practitioners with direct expertise in the specific technical area of the patent—researchers or engineers who work in the same technical domain and who have professional knowledge of the field's history and current state. A letter from an expert who does not work in the specific technical area may acknowledge the patent's existence without being able to assess its significance, which provides less probative value than a letter from a directly relevant expert who can specifically address the technical significance of the claims.

The expert's assessment of the patent should address the originality of the contribution in terms that a non-specialist can understand: what problem did the invention solve, what approaches existed before this invention, and how does this invention improve on or differ from those prior approaches? The assessment should also address the major significance element: how has this invention been adopted, cited, or built upon by others in the field, and what does that adoption pattern indicate about the invention's impact on how practitioners in the field work? An expert who can speak specifically to having read the patent, evaluated the claims, and assessed the invention against the current state of the art in the relevant field is providing the kind of independent professional evaluation that USCIS finds most probative.

When the beneficiary has multiple patents, the petition should present the strongest two or three patents in depth—with full citation analysis, expert letter support, and commercial significance documentation—rather than listing all patents on a CV and providing minimal documentation for each. The depth of evidence for the strongest patents is more persuasive than the breadth of a large patent portfolio with shallow documentation. A single patent with 50 citations, two licensing agreements, expert letters from recognized authorities explaining its significance, and press coverage in a recognized technical publication is a more persuasive original contribution showing than ten patents with no citations, no licensing activity, and no expert context.

Practical steps for assembling patent evidence in an O-1A petition

The practical steps for assembling patent evidence begin with a complete inventory of the beneficiary's patent portfolio: all granted patents, pending applications, and any patents that have been assigned to employers or co-inventors. For each granted patent, the beneficiary and their attorney should conduct a citation search to establish the current citation count and identify any notable citing patents or licensing activity. This inventory provides the baseline from which the petition strategy for the patents criterion is developed: identifying which patents have the strongest citation and commercial records, which expert contacts are best positioned to speak to those specific patents, and how the patent evidence relates to the other criteria in the petition.

Documentation for each featured patent should be collected and organized before petition drafting begins. The documentation package for a granted US patent typically includes: a printed copy of the issued patent from the USPTO Patent Center or Google Patents, confirming the patent number, inventors, assignee, and claims; a citation report showing the total citation count and listing at least the top citing patents with the names of the citing inventors and their institutional affiliations; any licensing agreement or assignment documentation (redacted for confidentiality if necessary, with a letter from counsel confirming the licensing relationship); and any press coverage, technical blog posts, or conference presentations by third parties that reference the patent or the underlying invention.

The timeline for assembling patent evidence is generally shorter than for other types of O-1A evidence, because the primary documentation—the patent itself and the citation data—is available from public databases and does not require third-party cooperation. The bottleneck is typically the expert letters, which must be solicited from practitioners in the specific technical field who have the expertise to assess the patent's significance. Identifying appropriate expert letter writers for patent-based original contribution claims requires finding individuals who are recognized researchers or practitioners in the specific technical domain covered by the patent, who can speak to the patent's significance from professional knowledge of the field, and who are willing to invest the time required to write a substantive, specific assessment.